354 related articles for article (PubMed ID: 25499988)
1. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents.
Eldehna WM; Altoukhy A; Mahrous H; Abdel-Aziz HA
Eur J Med Chem; 2015 Jan; 90():684-94. PubMed ID: 25499988
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and in vitro antiproliferative activity of novel isatin-quinazoline hybrids.
Fares M; Eldehna WM; Abou-Seri SM; Abdel-Aziz HA; Aly MH; Tolba MF
Arch Pharm (Weinheim); 2015 Feb; 348(2):144-54. PubMed ID: 25664631
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel isatin-dehydroepiandrosterone conjugates as potential anticancer agents.
Ke S; Shi L; Yang Z
Bioorg Med Chem Lett; 2015 Oct; 25(20):4628-31. PubMed ID: 26320625
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
6. Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents.
Ibrahim HS; Abou-Seri SM; Ismail NSM; Elaasser MM; Aly MH; Abdel-Aziz HA
Eur J Med Chem; 2016 Jan; 108():415-422. PubMed ID: 26706352
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds.
Wang J; Yun D; Yao J; Fu W; Huang F; Chen L; Wei T; Yu C; Xu H; Zhou X; Huang Y; Wu J; Qiu P; Li W
Eur J Med Chem; 2018 Jan; 144():493-503. PubMed ID: 29288946
[TBL] [Abstract][Full Text] [Related]
9. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
[TBL] [Abstract][Full Text] [Related]
11. Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents.
Maddela S; Makula A; Jayarambabu N
Anticancer Agents Med Chem; 2017; 17(3):456-463. PubMed ID: 27173964
[TBL] [Abstract][Full Text] [Related]
12. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
Abreu RM; Ferreira IC; Calhelha RC; Lima RT; Vasconcelos MH; Adega F; Chaves R; Queiroz MJ
Eur J Med Chem; 2011 Dec; 46(12):5800-6. PubMed ID: 22014996
[TBL] [Abstract][Full Text] [Related]
13. Novel Thiazolidinone/Thiazolo[3,2-
El-Naggar M; Eldehna WM; Almahli H; Elgez A; Fares M; Elaasser MM; Abdel-Aziz HA
Molecules; 2018 Jun; 23(6):. PubMed ID: 29895744
[TBL] [Abstract][Full Text] [Related]
14. New di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, growth inhibitory activity on human tumor cell lines and non-tumor cells, effects on cell cycle and on programmed cell death.
Queiroz MJ; Peixoto D; Calhelha RC; Soares P; Dos Santos T; Lima RT; Campos JF; Abreu RM; Ferreira IC; Vasconcelos MH
Eur J Med Chem; 2013 Nov; 69():855-62. PubMed ID: 24121236
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and molecular modeling of biquinoline-pyridine hybrids as a new class of potential EGFR and HER-2 kinase inhibitors.
Sangani CB; Makawana JA; Duan YT; Yin Y; Teraiya SB; Thumar NJ; Zhu HL
Bioorg Med Chem Lett; 2014 Sep; 24(18):4472-4476. PubMed ID: 25172421
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives.
Prachayasittikul V; Pingaew R; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Sep; 84():247-63. PubMed ID: 25019480
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer properties of novel hydrazone derivatives incorporating pyridine and isatin moieties.
Zebbiche Z; Tekin S; Küçükbay H; Yüksel F; Boumoud B
Arch Pharm (Weinheim); 2021 May; 354(5):e2000377. PubMed ID: 33368627
[TBL] [Abstract][Full Text] [Related]
19. QSAR study of isatin analogues as in vitro anti-cancer agents.
Sabet R; Mohammadpour M; Sadeghi A; Fassihi A
Eur J Med Chem; 2010 Mar; 45(3):1113-8. PubMed ID: 20056518
[TBL] [Abstract][Full Text] [Related]
20. H2O-mediated isatin spiro-epoxide ring opening with NaCN: Synthesis of novel 3-tetrazolylmethyl-3-hydroxy-oxindole hybrids and their anticancer evaluation.
Sharma P; Senwar KR; Jeengar MK; Reddy TS; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Nov; 104():11-24. PubMed ID: 26413726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
